Recent studies on microbial cytochrome P450 enzymes cover several new areas. Advances have been made in structure-function analysis. New nonenzymatic/electrochemical systems for the replacement of NAD(P)H have been developed. The properties of some enzymes have been re-engineered by site-directed mutagenesis or by methods of directed evolution. New P450s have been functionally expressed and characterized. A combination of these approaches is believed to facilitate the use of isolated P450 monooxygenases in biocatalysis.
Introduction
While enzymes are widely used in industry for regio-or stereospecific hydrolysis, for chiral ester synthesis and isomerization reactions, biological oxidation has yet to be Recently, several groups have started to investigate these cytochrome P450 monooxygenases (also called CYP) for use in biotransformations employing the isolated enzymes. These are a potentially very useful class of catalysts for oxidation as they are able to introduce oxygen at non-activated carbon-hydrogen bonds to yield sterically and optically-pure compounds. In addition, they present one of the largest superfamilies of enzyme proteins known: genes coding for diverse P450 monooxygenases have been found in virtually all living organisms -in bacteria, algae, plants as well as in humans [*3,*4] , and the number of CYP encoding sequences now amounts to over 660 (http://www.icgeb.trieste.it/~p450srv/new/p450.html). The reactions catalyzed by CYPs are quite diverse and range from the participation in the biosynthesis of hormones in animals and secondary metabolites in plants to the biodegradation of xenobiotic compounds. Mammalian CYPs, located in the liver microsomes, have been widely studied in the context of drug activation and the liver's response to toxic chemicals. However, there are considerable challenges in any application of isolated P450 enzymes in biocatalytic reactions. They are intrinsically not very active and exhibit poor stability in an isolated form. They require associated proteins such as ferredoxin and FMN-reductases for electron transfer, these complexes often being membrane-associated. Furthermore, as NAD(P)H, the cofactor of CYP-catalyzed reactions, is consumed in the reaction, a technical process is required to supply or regenerate this expensive chemical continuously. As a result, the search for alternative co-factors, or for NAD(P)H-regeneration, has met with great interest.
In spite of these difficulties, the development of efficient CYP biocatalysts has been initiated in several groups [*5]. Their work includes:
• a better understanding of structural features relating to the mechanism
• inexpensive electron transfer systems
• rapid, sensitive and automated high throughput screening methods
• the generation of more selective mutant enzymes.
In this review, we summarize the studies on the aspects on prokaryotic CYP enzymes mentioned above, most of which were published in 2001-2002.
Structure and function
Rational design of an enzyme requires a solid structural basis and an understanding of its catalytic mechanism. The structures of CYPs determined by X-ray crystallography at high-resolution have provided some of this information [6] [7] [8] [9] [10] [11] [12] [13] . In spite of quite low sequence identity of < 20 %, all eight enzyme structures resolved so far demonstrate quite close structural similarity (as example the structure of P450 BM-3, Figure 2 ).
Their tertiary structure is composed of both α-helixes and β-sheets, with significant dominance of the α-helical regions. Both crystal forms diffracted to 0.25 nm resolution and preliminary X-ray data were recorded using synchrotron radiation. CYP152A1 is an unusual peroxygenase which catalyses the hydroxylation of fatty acids by introducing an oxygen atom from H 2 O 2 at the C α -or C ß -carbon. Using lysine scanning mutagenesis of amino acids in the putative distal helix, residues with a putative mechanistic role were determined [23] .
Further mutagenesis revealed that P243, which is located close to the heme iron, plays an important role in the hydrophobic interaction with the substrate, whereas R224 is a critical residue for substrate binding and H 2 O 2 -specific catalysis.
Artificial electron-transfer systems
CYPs are hydroxylating enzymes, in which the addition of one atom of molecular oxygen activated by heme iron represents the essential step in the oxidation of a substrate. The second oxygen atom is reduced to water, using electron transfer from NAD(P)H via a flavoprotein or a ferredoxin. In a non-productive side-path ("peroxide shunt"), hydrogen peroxide may be employed as a source of both electrons and oxygen. have assembled an artificial redox chain in a chimeric fusion protein, using the heme irradiation of cytochrome P450 leads to the photoreduction of riboflavin, followed by the reduction of the heme iron. CYP102. Several groups have addressed the question of chain-length specificity of this enzyme. In a procedure termed "rational evolution" by the authors (protein design combined with directed evolution), substrate specificity was shifted from C-12 fatty acids to C-10 and C-8 in the fatty acid pseudosubstrates 10-and 8-pnitrophenoxycarboxylic acid [42] . Three different mutants (A74G/F87V/L188Q; R47F/A74G/F87V/L188Q and V26T/R47F /A74G/F87V/L188Q) showed the same behavior, though in different ratios. The same mutants also showed activity towards the free C-8 and C-10 fatty acids [37] . Arnold and colleagues have studied directed evolution for the conversion of CYP102 into an efficient octane hydroxylase [43] .
Assays
They succeeded in generating mutants which accepted n-octane. The screening for alkane oxidation activity was based on a substrate analogue which generated, after terminal hydroxylation, aldehyde and yellow p-nitrophenolate (Figure 4 ). After two rounds of error-prone PCR, the screening of 3000 clones led to some variants that were approximately 6 times more active towards n-octane than the wild type. The same group continued to evolve the heme domain of this enzyme for an enhanced Inexpensive methods of cofactor regeneration are also the focus of several research groups. It can be safely assumed that the large potential of CYP enzymes for selective hydroxylation of non-activated carbon-hydrogen bonds will further stimulate biotechnologists to adapt this important enzyme class to the needs of technology. The overview describes considerable progress in oxidative biotransformations using oxygenases (hydroxylation, Baeyer-Villiger oxidation, epoxidation, peroxidation dihydroxylation). This review provides the general information about gene organization, structural features, localization and functions and enzyme mechanism of P450s and defines the major unsolved issues in this field. 
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